Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome

Summary

To compare efficacy and safety of dalteparin compared to unfractionated heparin in patients of non ST elevation acute coronary syndromes who are planned to undergo coronary interventions (angioplasty or bypass surgery)

Timeline

Start

2007-06

Primary completion

2008-12

Completion

2008-12

Outcome

Met primary endpoint

Stopped: “See termination reason in detailed description.”

registry Difference in proportion -1.35 (95% CI -8.62 to 5.93); upper limit of 95% CI <= 10% NCT00435487 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dalteparin sodium	Other / unclassified	120 iu/kg	Subcutaneous
Comparator	HEPARIN CALCIUM	Other / unclassified	12 iu/kg	Intravenous

Indications